Eigenlijk had je zelf wat initiatief kunnen tonen door je te verdiepen in de materie. Hierbij geef ik je een 15-tal referenties. Maar ik kan je er nog minstens 30 geven met dezelfde strekking. En denk nou niet wat voor HIVplussers geldt niet opgaat voor HIV-minners!
Happy reading
1. J Falutz and others. A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation. AIDS 19(12):1279-1287. August 12, 2005.
2. J Clin Endocrinol Metab 2005;90:2154-2160.
3.J C Lo and others. The Effects of Low-Dose Growth Hormone in HIV-Infected Men with Fat Accumulation: A Pilot Study. Clinical Infectious Diseases 39:732-735. September 1, 2004.
4. J C Lo, K Mulligan, M A Noor, et al. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab 86: 34803487. 2001.
5. Serono, Inc. Serono initiates phase III trial of serostim in HIV-associated adipose redistribution syndrome. Press Release. June 1, 2004.
6.G J Moyle and others. Growth Hormone Improves Lean Body Mass, Physical Performance, and Quality of Life in Subjects With HIV-Associated Weight Loss or Wasting on Highly Active Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes 35(4): 367-375. April 1, 2004.
7. D P Kotler and others. Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes 35(3): 239-252. March 1, 2004.
8. U R Hengge and others. Oxymetholone for the Treatment of HIV Wasting: A Double-blind, Randomized, Placebo-controlled Phase 3 Trial in Eugonadal Men and Women. Abstract 725 (poster). Program and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (11th CROI). February 8-11, 2004. San Francisco, CA.
9. D P Kotler and others (for the Serostim in the Treatment of Adipose Redistribution Syndrome (STARS) Trial Investigator Group). Low Dose Maintenance Therapy with Recombinant Human Growth Hormone (r-hGH) Sustains Effects of Previous r-hGH Treatment in HIV+ Patients with Excess Central Fat: Treatment Results at 60 Weeks. Abstract 80 (oral). Program and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (11th CROI). February 8-11, 2004. San Francisco, CA.
10. A Vigano and others. Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents. AIDS 17(10): 1435-1441. July 4, 2003.
11. JN Roemmich and others. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: Relation to adiposity, body fat distribution and hormone release. International Journal of Obesity 2002, 26: 701-709
12. Engelhard P, Strawbridge T. The use of growth hormone (Serostim) in patients with HIV-associated adipose redistribution syndrome (HARS). Program and abstracts of the XIII International AIDS Conference, Durban, South Africa; July 9-14, 2000. Abstract TuPeB3151.
13. Furrer H, Nguyen QV, Malinvern R. Treatment of HAART associated fat accumulation disease with recombinant human growth hormone: Results of a randomized double blind placebo controlled crossover trial. Program and abstracts of the XIII International AIDS Conference, Durban, South Africa; July 9-14, 2000. Abstract LbPp114.
14. Lo JC, Mulligan K, Noor M et al. The effects of recombinant human growth hormone on glucose metabilism and body composition in HIV-positive subjects with fat accumulation syndromes. 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada; September 13-15. Abstract 12.
15. Torres R, Cadman JA. Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome. BioDrugs. 2000;14.
16. Wanke C, Gerrior J, Kantaros J et al. Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS. 1999;13;2099-2103
Etcetera !!!!!
MightyDuck zei:
Dat mag je dan wel eens doen dat zou ik graag lezen, ik heb tot nu toe nog niemand gehoord die het cut effect van STH kan verkláren op een manier die verder gaat dan "ja die en die gebruikte het en werd heel droog"